Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tushar Patel

Showing results (221-230 of 273) with videos related to

Pageof 28
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2022
Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort StudyLorena Marcano-Bonilla, Cathy D Schleck, William S Harmsen, et al.
Theranostics|November 8, 2019
Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNARyan A Hlady, Xia Zhao, Xiaoyu Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Nicola Valeri, Pierluigi Gasparini, Chiara Braconi, et al.
Cancer Research|October 20, 2011
miR-221 silencing blocks hepatocellular carcinoma and promotes survivalJong-Kook Park, Takayuki Kogure, Gerard J Nuovo, et al.
Cancers|April 3, 2021
Aspirin and Statin Use and the Risk of Gallbladder CancerKritika Prasai, Sri Harsha Tella, Siddhartha Yadav, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 10, 2003
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated ratsMarco Marzioni, Gene D LeSage, Shannon Glaser, et al.
Cell Reports|November 1, 2018
Large Differences in Small RNA Composition Between Human BiofluidsPaula M Godoy, Nirav R Bhakta, Andrea J Barczak, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 12, 2024
Albumin promoter-driven FlpO expression induces efficient genetic recombination in mouse liverXiaohui Zhu, Yan Yang, Dongfeng Feng, et al.
Cancer Research|December 17, 2005
gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathwayGiammarco Fava, Luca Marucci, Shannon Glaser, et al.
Cancer Research|January 2, 2026
Editor's Note: γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP-Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 PathwayGiammarco Fava, Luca Marucci, Shannon Glaser, et al.
Pageof 28

Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2022
Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort StudyLorena Marcano-Bonilla, Cathy D Schleck, William S Harmsen, et al.
Theranostics|November 8, 2019
Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNARyan A Hlady, Xia Zhao, Xiaoyu Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Nicola Valeri, Pierluigi Gasparini, Chiara Braconi, et al.
Cancer Research|October 20, 2011
miR-221 silencing blocks hepatocellular carcinoma and promotes survivalJong-Kook Park, Takayuki Kogure, Gerard J Nuovo, et al.
Cancers|April 3, 2021
Aspirin and Statin Use and the Risk of Gallbladder CancerKritika Prasai, Sri Harsha Tella, Siddhartha Yadav, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 10, 2003
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated ratsMarco Marzioni, Gene D LeSage, Shannon Glaser, et al.
Cell Reports|November 1, 2018
Large Differences in Small RNA Composition Between Human BiofluidsPaula M Godoy, Nirav R Bhakta, Andrea J Barczak, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 12, 2024
Albumin promoter-driven FlpO expression induces efficient genetic recombination in mouse liverXiaohui Zhu, Yan Yang, Dongfeng Feng, et al.
Cancer Research|December 17, 2005
gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathwayGiammarco Fava, Luca Marucci, Shannon Glaser, et al.
Cancer Research|January 2, 2026
Editor's Note: γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP-Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 PathwayGiammarco Fava, Luca Marucci, Shannon Glaser, et al.
Pageof 28